MSCs from Amniotic Membrane for ALS (Motor Neurone Disease)

How Stem Plus applies MSCs from Amniotic Membrane within a personalised ALS (Motor Neurone Disease) protocol — in the EU, from €3,000–€8,000.

For ALS (Motor Neurone Disease), MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for ALS (Motor Neurone Disease). Compare them on the ALS (Motor Neurone Disease) overview, or see the MSCs from Amniotic Membrane page.

GMP-certified MSCs from Amniotic Membrane, characterised and viability-tested
Physician-led ALS (Motor Neurone Disease) protocol
Transparent €3,000–€8,000 pricing
Remote follow-up worldwide

Educational information; investigational for several conditions. Outcomes vary.

Thérapie cellulaire de niveau européen, sans les prix européens.

Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.

Évaluation médicale gratuite

MSCs from Amniotic Membrane for ALS (Motor Neurone Disease)

Related

Thérapie cellulaire de niveau européen, sans les prix européens.